Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients [published erratum appears in Am J Psychiatry 1996 Apr;153(4):588]

Back to table of contents Previous article Next article No AccessDemonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients [published erratum appears in Am J Psychiatry 1996 Apr;153(4):588]Published Online:1 Apr 2006https://doi.org/10.1176/ajp.153.2.174AboutSectionsView articleAbstractPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail View articleAbstractOBJECTIVE: For over 25 years, it has been hypothesized that major depression is due to a deficiency of available serotonin or subsensitivity of key serotonin receptors in relevant brain regions. Direct evidence supporting this hypothesis has been lacking because of the difficulty in studying regional brain serotonergic function. The authors have developed a method for visualizing in vivo regional brain responses to serotonin release by comparing regional brain glucose metabolism after administration of the serotonin-releasing drug dl- fenfluramine, relative to placebo. METHOD: Results with healthy subjects (N = 6) were compared to those obtained with drug-free inpatients with moderately severe major depression (N = 6). RESULTS: Healthy subjects had several areas of statistically significant increases in metabolism, mostly in the left prefrontal and temporoparietal cortex, and areas of decreased metabolism, such as in the right prefrontal cortex. In contrast, the depressed patients had no areas of increase or decrease in metabolism, differing significantly from healthy subjects. Results with patients resembled those with healthy subjects (N = 10) who were scanned twice without active drug on either occasion. CONCLUSIONS: This study provides the first direct visualization of blunted regional brain responses to serotonin release in the brain of patients with major depression, a finding that supports the hypothesis of impaired serotonergic transmission in depression. Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login Sign in via OpenAthens Purchase Save for later Item saved, go to cart PPV Articles - American Journal of Psychiatry $35.00 Add to cart PPV Articles - American Journal of Psychiatry Checkout Please login/register if you wish to pair your device and check access availability. Not a subscriber? Subscribe Now / Learn More PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development. Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.). FiguresReferencesCited byDetailsCited byShared and unique imaging-derived endo-phenotypes of two typical antidepressant-applicative depressive patients18 August 2022 | European Radiology, Vol. 33, No. 1Brain Perfusion Bridges Virtual-Reality Spatial Behavior to TPH2 Genotype for Head Acceleration EventsJournal of Neurotrauma, Vol. 38, No. 10Suicide and Attempted SuicideNeuroscience Bulletin, Vol. 31, No. 1Current Opinion in Pharmacology, Vol. 14Frontiers in Behavioral Neuroscience, Vol. 8Archives of Suicide Research, Vol. 17, No. 4The impact of maternal high-fat diet consumption on neural development and behavior of offspring11 December 2012 | International Journal of Obesity Supplements, Vol. 2, No. S2Journal of Osteoporosis, Vol. 2012Sexual Disorders Caused by Antidepressants: Considerations in the Context of Brain Hemisphere Functions23 February 2017 | Activitas Nervosa Superior, Vol. 52, No. 2Molecular Neurobiology, Vol. 38, No. 3Journal of Neuroendocrinology, Vol. 19, No. 8Psychopharmacology, Vol. 185, No. 2A Theory Explaining Biological Correlates of Criminality24 July 2016 | European Journal of Criminology, Vol. 2, No. 3Neuropsychopharmacology, Vol. 30, No. 6Deficits in Hippocampal and Anterior Cingulate Functioning During Verbal Declarative Memory Encoding in Midlife Major DepressionJ. Douglas Bremner, M.D., Meena Vythilingam, M.D., Eric Vermetten, M.D., Viola Vaccarino, M.D., Ph.D., and Dennis S. Charney, M.D.1 April 2004 | American Journal of Psychiatry, Vol. 161, No. 4Anterior Cingulate, Gyrus Rectus, and Orbitofrontal Abnormalities in Elderly Depressed Patients: An MRI-Based Parcellation of the Prefrontal CortexMartina Ballmaier, M.D., Arthur W. Toga, Ph.D., Rebecca E. Blanton, B.S., Elizabeth R. Sowell, Ph.D., Helen Lavretsky, M.D., Jeffrey Peterson, B.S., Daniel Pham, B.S., and Anand Kumar, M.D.1 January 2004 | American Journal of Psychiatry, Vol. 161, No. 1Impaired Repression at a 5-Hydroxytryptamine 1A Receptor Gene Polymorphism Associated with Major Depression and Suicide24 September 2003 | The Journal of Neuroscience, Vol. 23, No. 25Response of Cortical Metabolic Deficits to Serotonergic Challenge in Familial Mood DisordersLawrence S. Kegeles, M.D., Ph.D., Kevin M. Malone, M.D., Mark Slifstein, Ph.D., Steven P. Ellis, Ph.D., Eric Xanthopoulos, B.S., John G. Keilp, Ph.D., Carl Campbell, B.S., Maria Oquendo, M.D., Ronald L. Van Heertum, M.D., and J. John Mann, M.D.1 January 2003 | American Journal of Psychiatry, Vol. 160, No. 1Human Psychopharmacology: Clinical and Experimental, Vol. 18, No. 4Nature Reviews Neuroscience, Vol. 4, No. 10Neuropsychopharmacology, Vol. 28, No. 2Psychophysiology, Vol. 40, No. 2Neurobiology and Genetics of Borderline Personality DisorderPsychiatric Annals, Vol. 32, No. 6Human Psychopharmacology: Clinical and Experimental, Vol. 17, No. 2Current Psychiatry Reports, Vol. 4, No. 1Brain aging research at the close of the 20th century: from bench to bedside1 April 2022 | Dialogues in Clinical Neuroscience, Vol. 3, No. 3Methamphetamine-Related Psychiatric Symptoms and Reduced Brain Dopamine Transporters Studied With PETYoshimoto Sekine, M.D., Ph.D., Masaomi Iyo, M.D., Ph.D., Yasuomi Ouchi, M.D., Ph.D., Tsutomu Matsunaga, M.D., Ph.D., Hideo Tsukada, Ph.D., Hiroyuki Okada, B.A., Etsuji Yoshikawa, B.A., Masami Futatsubashi, B.A., Nori Takei, M.D., Ph.D., M.Sc., and Norio Mori, M.D., Ph.D.1 August 2001 | American Journal of Psychiatry, Vol. 158, No. 8Decreased Regional Brain Metabolism After ECTMitchell S. Nobler, M.D., Maria A. Oquendo, M.D., Lawrence S. Kegeles, M.D., Ph.D., Kevin M. Malone, M.D., Carl Campbell, M.A., Harold A. Sackeim, Ph.D., and J. John Mann, M.D.1 February 2001 | American Journal of Psychiatry, Vol. 158, No. 2Depression and Anxiety, Vol. 14, No. 2Human Psychopharmacology: Clinical and Experimental, Vol. 16, No. 1Human Psychopharmacology: Clinical and Experimental, Vol. 16, No. 3Human Psychopharmacology: Clinical and Experimental, Vol. 16, No. 3Current Hypertension Reports, Vol. 3, No. 1Psychiatry Research: Neuroimaging, Vol. 98, No. 3Alcoholism: Clinical and Experimental Research, Vol. 24, No. 7Journal of the American Academy of Psychoanalysis, Vol. 28, No. 3Neuropharmacology and Receptor Studies in the Elderly29 June 2016 | Journal of Geriatric Psychiatry and Neurology, Vol. 12, No. 3Depression and Anxiety, Vol. 10, No. 4No Effect of Depression on [15O]H2O PET Response to Intravenous d-FenfluramineJeffrey H. Meyer, M.D., Sidney Kennedy, M.D., and Gregory M. Brown, M.D., Ph.D.1 September 1998 | American Journal of Psychiatry, Vol. 155, No. 9Differences and variability in plasma noradrenaline between depressive and anxiety disorders1 July 2016 | Journal of Psychopharmacology, Vol. 12, No. 2Synapse, Vol. 30, No. 4Cognition & Emotion, Vol. 12, No. 3Journal of Clinical Psychopharmacology, Vol. 18, No. 6Anterior cingulate gyrus volume and glucose metabolism in autistic disorder1 April 2006 | American Journal of Psychiatry, Vol. 154, No. 8A Review of Functional Neuroimaging in Mood Disorders: Positron Emission Tomography and Depression1 June 1997 | The Canadian Journal of Psychiatry, Vol. 42, No. 5Serotonergic modulation of dopamine measured with [11C]raclopride and PET in normal human subjects1 April 2006 | American Journal of Psychiatry, Vol. 154, No. 4Reduced serotonin responsivity in depression7 October 2014 | American Journal of Psychiatry, Vol. 154, No. 3Deteriorated affective disorder a rarity?7 October 2014 | American Journal of Psychiatry, Vol. 154, No. 3Journal of Neural Transmission, Vol. 104, No. 8-9Current Opinion in Psychiatry, Vol. 10, No. 2Annals of the New York Academy of Sciences, Vol. 836, No. 1 Neurobiology Volume 153Issue 2 February 1996Pages 174-182 Metrics PDF download History Published online 1 April 2006 Published in print 1 February 1996